Pharvaris N.V.
PHVS
$28.15
$4.0316.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -13.57% | 0.33% | 11.51% | 60.54% | 59.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.29% | 23.82% | 44.44% | 64.26% | 46.11% |
| Operating Income | -11.29% | -23.82% | -44.44% | -64.26% | -46.11% |
| Income Before Tax | 4.33% | -60.96% | -60.92% | -3.72% | -78.65% |
| Income Tax Expenses | -183.87% | 202.76% | 2.91% | 64.09% | 58.92% |
| Earnings from Continuing Operations | 5.32% | -61.30% | -60.33% | -5.10% | -78.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.32% | -61.30% | -60.33% | -5.10% | -78.53% |
| EBIT | -11.29% | -23.82% | -44.44% | -64.26% | -46.11% |
| EBITDA | -11.28% | -23.92% | -44.63% | -64.23% | -46.33% |
| EPS Basic | 17.77% | -59.08% | -58.16% | 14.49% | -35.09% |
| Normalized Basic EPS | 16.90% | -58.77% | -58.73% | 15.62% | -35.15% |
| EPS Diluted | 17.77% | -59.08% | -58.16% | 14.49% | -35.09% |
| Normalized Diluted EPS | 16.90% | -58.77% | -58.73% | 15.62% | -35.15% |
| Average Basic Shares Outstanding | 15.14% | 1.39% | 1.38% | 22.91% | 32.17% |
| Average Diluted Shares Outstanding | 15.14% | 1.39% | 1.38% | 22.91% | 32.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |